Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+86-755-26582888
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
Mindray Medical International (NYSE:MR) Frequently Asked Questions
What is Mindray Medical International's stock symbol?
Mindray Medical International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MR."
How were Mindray Medical International's earnings last quarter?
Mindray Medical International Ltd (NYSE:MR) issued its quarterly earnings results on Friday, November, 13th. The medical instruments supplier reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.32 by $0.19. The medical instruments supplier had revenue of $327.60 million for the quarter. During the same quarter in the previous year, the business earned $0.47 EPS. View Mindray Medical International's Earnings History.
Has Mindray Medical International been receiving favorable news coverage?
News articles about MR stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Mindray Medical International earned a coverage optimism score of 1.3 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of Mindray Medical International?
Shares of MR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mindray Medical International's stock price today?
One share of MR stock can currently be purchased for approximately $1.11.
What is Mindray Medical International's official website?
How can I contact Mindray Medical International?
Mindray Medical International's mailing address is Mindray Building Keji 12th Road South, Hi-tech Ind. Park Nanshan, SHENZHEN, GNG 518057, China. The medical instruments supplier can be reached via phone at +86-755-26582888.
MarketBeat Community Rating for Mindray Medical International (NYSE MR)
MarketBeat's community ratings are surveys of what our community members think about Mindray Medical International and other stocks. Vote "Outperform" if you believe MR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MR will underperform the S&P 500 over the long term. You may vote once every thirty days.
